Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David van Duin, MD, PhD
University of North Carolina
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Harbor-University of California Los Angeles Medical Center
Torrance, California, United States
- University of Colorado Denver
Aurora, Colorado, United States
- Emory University
Atlanta, Georgia, United States
- Ochsner Medical Center
New Orleans, Louisiana, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- University of Michigan Health System
Ann Arbor, Michigan, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Weill Cornell Medical College
New York, New York, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- the University of Texas Health Science Center at Houston
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Nov 2020
- Primary completion
- 1 Jun 2021
- Completion
- 1 Jun 2021
- Last update posted
- 27 Jul 2021
- Registered enrollment
- 300
- Registry id
- NCT04574596
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.